Business / Finance RSS Feed - Business / Finance

Astute Medical, OCD partner to expand access to new acute kidney injury test

Astute Medical, OCD partner to expand access to new acute kidney injury test

Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury (AKI), a prevalent and deadly condition. [More]

Psychemedics' Q2 revenue increases 12% to $7.7 million

Psychemedics Corporation today announced second quarter financial results for the period ended June 30, 2014. The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of August 7, 2014 to be paid on August 18, 2014. [More]
athenahealth expands strategic agreement with Henry Schein

athenahealth expands strategic agreement with Henry Schein

athenahealth, Inc., a leading provider of cloud-based services for electronic health record (EHR), practice management, and care coordination, and Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, today announced an expansion of their strategic agreement announced on May 21, 2014. [More]
Avidus acquires Truestar Health

Avidus acquires Truestar Health

Avidus Management Group Inc. is pleased to announce that further to its news release of July 16, 2014, it has completed the acquisition of substantially all of the assets of Truestar Health Inc., a Toronto based network-marketing company (the "Acquisition"). [More]

Syneron Medical to host investor meeting to highlight opportunities in body contouring/fat treatment market

Syneron Medical Ltd., a leading global aesthetic device company, announced today that it will host an investor meeting on Wednesday, September 17, 2014, at approximately 10:00 am to 1:00 pm ET in New York City. The meeting will highlight Syneron's opportunity in the fast growing body contouring and fat treatment market, with a focus on the UltraShape system, which received FDA clearance for fat cell destruction in April 2014. [More]
CanTx, Novogen name two key CMOs to manufacture clinical batches of anti-cancer drug Cantrixil

CanTx, Novogen name two key CMOs to manufacture clinical batches of anti-cancer drug Cantrixil

Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd., today announced that they have named two key contract manufacturing organizations (CMOs) to produce clinical batches of the experimental anti-cancer drug, Cantrixil. [More]
Semler Scientific revenues increase $371,000 to 78% in second quarter 2014

Semler Scientific revenues increase $371,000 to 78% in second quarter 2014

Semler Scientific, Inc., an emerging medical risk assessment company that develops patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today reported financial results for the second quarter and six months ended June 30, 2014. [More]
GNC Holdings declares quarterly cash dividend for third quarter 2014

GNC Holdings declares quarterly cash dividend for third quarter 2014

The Board of Directors of GNC Holdings, Inc. (the "Company") authorized and declared the quarterly cash dividend for the third quarter of 2014 of $0.16 per share of the Company's common stock. [More]
Bitcoin Collect acquires medical device company, Good Vibration Shoes

Bitcoin Collect acquires medical device company, Good Vibration Shoes

Bitcoin Collect, Inc., today announced that it has discontinued its plans to develop virtual currency software, and has acquired a company with an exciting proprietary product in the medical devices industry. [More]
Todd Mitchem Consulting to conduct cannabis business workshops in early fall

Todd Mitchem Consulting to conduct cannabis business workshops in early fall

Todd Mitchem Consulting, in conjunction with Cannabrand, the first full-service recreational cannabis marketing agency, will present "I Choose Cannabis and Business" workshops slated for five cities in September and October 2014. [More]
Amgen declares share dividend for third quarter 2014

Amgen declares share dividend for third quarter 2014

Amgen announced that its Board of Directors today declared a $0.61 per share dividend for the third quarter of 2014. [More]
Solanbridge Group acquires majority interest in Buzznbrewz.com

Solanbridge Group acquires majority interest in Buzznbrewz.com

Solanbridge Group Inc is pleased to announce that SLNX has acquired the majority interest in Buzznbrewz.com and the Letter of Intent issued on July 11, 2014 has been replaced with a fully executed Purchase Agreement. [More]
Galmed reports net loss of $3.9 million for six months ended June 30, 2014

Galmed reports net loss of $3.9 million for six months ended June 30, 2014

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones, today announced financial results for the period ended June 30, 2014. [More]
IDEXX revenues increase 11% to $390M in second quarter 2014

IDEXX revenues increase 11% to $390M in second quarter 2014

IDEXX Laboratories, Inc. today reported that revenues for the second quarter of 2014 increased 11% versus the prior year period to $390 million. [More]
Malvern acquires MicroCal business and Affinity Biosensors' Archimedes product

Malvern acquires MicroCal business and Affinity Biosensors' Archimedes product

Malvern Instruments Ltd (Malvern, UK) has today announced that it has completed the acquisition of MicroCal from GE Healthcare Life Sciences and has also purchased the Archimedes particle characterization system from Affinity Biosensors LLC (Santa Barbara, CA). [More]
WIRB-Copernicus Group acquires Alliance Biosciences

WIRB-Copernicus Group acquires Alliance Biosciences

WIRB-Copernicus Group, the world's largest provider of regulatory and ethical review services for clinical research, announced today that it has acquired Alliance Biosciences. Formerly a division of Richmond, VA-based Alliance Engineering, Alliance Biosciences was the leading biosafety and biosecurity consulting firm in the United States. [More]
Cypher Genomics, Illumina partner to facilitate development of genomic-based biomarkers

Cypher Genomics, Illumina partner to facilitate development of genomic-based biomarkers

Cypher Genomics, Inc., the genome informatics company, announced today a co-promotion agreement with Illumina to facilitate the development of genomic-based biomarkers from whole genome sequence data for precision medicine and clinical trials. [More]
Pixcelldata announces new partnership with Basys Data

Pixcelldata announces new partnership with Basys Data

Pixcelldata, the innovative Irish developer of Collibio digital pathology management and collaboration software has announced a partnership with Basys Data, the provider of PathoWin+ LIMS software to pathology laboratories in Switzerland. [More]
Shire, ArmaGen partner to develop AGT-182 drug for treatment of Hunter syndrome

Shire, ArmaGen partner to develop AGT-182 drug for treatment of Hunter syndrome

Shire plc, the global specialty biopharmaceutical company, and ArmaGen, a US privately held biotechnology company, today announced a worldwide licensing and collaboration agreement for AGT-182, an investigational enzyme replacement therapy (ERT) for the potential treatment of both the central nervous system (CNS) and somatic manifestations in patients with Hunter syndrome (MPS II). [More]
National Med Care partners with Taking You Forward for marketing pharmaceutical products in the U.S.

National Med Care partners with Taking You Forward for marketing pharmaceutical products in the U.S.

Richmond Private Equity Group Limited announced today that its "portfolio company", National Med Care Ltd, a Salt Lake City Utah, based pharmaceutical marketing firm has entered into an agreement with Taking You Forward Inc., a Cebu Philippines based BPO firm to form a joint venture for the marketing of its compound pharmaceutical products in the United States. [More]